Endurant Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,596	Closed	-$1.09M	–	50
2022 Q4	$1.09M	Buy	+4,596	New	+$1.09M	0.44%	37
2022 Q2	–	Sell	-10,379	Closed	-$1.7M	–	50
2022 Q1	$1.7M	Buy	+10,379	New	+$1.7M	0.45%	41